Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
05/2007
05/18/2007WO2007055273A1 Cation compound, dye compound and use thereof, and optical information recording medium
05/18/2007WO2007055183A1 Benzene derivative or salt thereof
05/18/2007WO2007054951A1 Process for amorphous esomeprazole
05/18/2007WO2007054770A2 Pyrazole derivatives and their medical use
05/18/2007WO2007054739A1 Tetrahydroindole derivatives for treatment of alzheimer's disease
05/18/2007WO2007054480A1 2-(benzimidazol-1-yl)-acetamide biaryl derivatives and their use as inhibitors of the trpv1 receptor
05/18/2007WO2007054453A2 Carbocyclic fused cyclic amines as inhibitors of the coagulation factor xa
05/18/2007WO2007054292A2 Azonafide derivatives, methods for their production and pharmaceutical compositions therefrom
05/18/2007WO2007054138A1 Substituted tetrahydroquinolines
05/18/2007WO2007054128A1 Novel inhibitors of the lfa-1/icam-1 interaction, and uses thereof
05/18/2007WO2007035841A9 Analogs of dehydrophenylahistins and their therapeutic use
05/18/2007WO2007031845A3 Polymorphic forms of (s)-omeprazole magnesium salts and processes for their preparation
05/18/2007WO2007029036A3 Amino acid derivatives as histone deacetylase (hdac) inhibitors
05/18/2007WO2007028083A3 6-arylalkylamino- 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
05/18/2007WO2007023073A3 Bicyclic heterocycles medicaments comprising said compounds use and method for production thereof
05/18/2007WO2007002635B1 C-linked cyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
05/18/2007WO2007002313A3 Phenylglycinamide and pyridylglycinamide derivatives useful as anticoagulants
05/18/2007WO2007002254A3 Benzocycloheptapyridines as inhibitors of the receptor tyrosine kinase met
05/18/2007WO2006138259A3 Chemokine receptor binding compounds
05/18/2007WO2006109085A8 Hydroxybenzamide derivatives and their use as inhibitors of hsp90
05/18/2007WO2006099605A3 Dimeric and trimeric nucleic acid dyes, and associated systems and methods
05/18/2007WO2006034474A3 Novel pyridine compounds, process for their preparation and compositions containing them
05/18/2007CA2669736A1 Heterocyclic compounds as tyrosine kinase modulators
05/18/2007CA2629258A1 Azonafide derivatives, methods for their production and pharmaceutical compositions therefrom
05/18/2007CA2628934A1 Tetrahydroindole derivatives for treatment of alzheimer's disease
05/18/2007CA2628260A1 2-phenyl-2h-pyraz0le derivatives as p2x7 receptor antagonists and uses thereof
05/18/2007CA2627426A1 Carbocyclic fused cyclic amines as inhibitors of the coagulation factor xa
05/18/2007CA2627263A1 2-(benzimidazol-1-yl)-acetamide biaryl derivatives and their use as inhibitors of the trpv1 receptor
05/18/2007CA2627114A1 P2x7 receptor antagonists and methods of use
05/18/2007CA2627085A1 Method for production 2-(4-methyl-2-phenylpiperazin-1-yl)pyridine-3-methanol
05/18/2007CA2626685A1 Benzimidazole derivatives as gyrase inhibitors
05/18/2007CA2611889A1 Substituted tetrahydroquinolines
05/17/2007US20070112205 Cyanopyrrolidine derivatives
05/17/2007US20070112192 3-(2-Hydroxy-phenyl)-1h-pyrazole-4-carboxylic acid amide derivatives as hsp90 inhibitors for the treatment of cancer
05/17/2007US20070112059 Cyanopyrrolidine derivatives
05/17/2007US20070112040 Amino nicotinate derivatives as glucokinase (GLK) modulators
05/17/2007US20070112037 Pyrazole Derivatives
05/17/2007US20070112036 Opioid receptor antagonists
05/17/2007US20070112027 Crystalline forms of a biphenyl compound
05/17/2007US20070112022 Piperidine derivatives as ccr5 receptor modulators
05/17/2007US20070112000 Chemical compounds
05/17/2007US20070111982 Calcitonin Gene-Related Peptide, CGRP; treatment of migraine and cluster headache; 2,5-dioxo-3',4'-dihydro-spiro(imidazolidine-4,2'(1'H)-naphthalene)-6'-carboxamides
05/17/2007US20070110806 Core contains acid-unstable drug and disintegrant, and release-controlling coating contains water-insoluble polymer, an enteric polymer and hydrophobic wax; capsules
05/16/2007EP1785418A1 Pyrazole derivative
05/16/2007EP1785415A1 Piperidine derivative or pharmaceutically acceptable salt thereof
05/16/2007EP1784401A1 Urea derivatives as calcium channel blockers
05/16/2007EP1784400A1 Histamine h3 receptor agents, preparation and therapeutic uses
05/16/2007EP1784399A2 Pyrimidine derivatives
05/16/2007EP1784396A2 Pyrazole-substituted aminoheteroaryl compounds as protein kinase inhibitors
05/16/2007EP1784394A1 Novel piperidine derivatives as histamine h3 receptor ligands for treatment of depression
05/16/2007EP1784393A1 Quinazolines useful as modulators of ion channels
05/16/2007EP1784392A2 Pyrimidine derivatives
05/16/2007EP1784390A2 Substituted benzofused heterocycles
05/16/2007EP1588145A4 Methods, mixtures, kits and compositions pertaining to analyte determination
05/16/2007EP1587788B1 2,7-substituted indoles and their use as 5-ht6 modulators
05/16/2007EP1434485B1 Nicotinic acid-heterocyclyl-amides and analogous pyrimidine derivatives for use as pesticides
05/16/2007EP1306373B1 3,4-dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient
05/16/2007EP1115405B1 Use of tnf-alpha inhibitors for treating nerve root injury
05/16/2007CN1964970A Iap的抑制剂 Iap inhibitors
05/16/2007CN1964964A Piperidine derivates for the treatment of chemokines mediared disease
05/16/2007CN1964957A Anionic-sweetener-based ionic liquids and methods of use thereof
05/16/2007CN1964953A Novel 3-phenyltetrahydrocinnolin-5-ol derivative and medicinal use thereof
05/16/2007CN1964952A Pyridazin-3(2h)-one derivatives and their use as PDE4 inhibitors
05/16/2007CN1964950A Propane-1,3-dione derivative or its salt
05/16/2007CN1964948A Therapeutic agents
05/16/2007CN1964946A 2-propylene-1-ones as hsp70 inducer
05/16/2007CN1964944A Indole derivatives as antiviral agents
05/16/2007CN1962655A Method for extracting nicotine from waste tobacco leaf through liquid film method
05/16/2007CN1962642A Trifluoromethylphenylpyridazine derivative and its preparation method
05/16/2007CN1962641A Metalloproteinase inhibitors
05/16/2007CN1315822C Quinoline derivatives having VEGF inhibiting activity
05/16/2007CN1315821C Improvement of preparation of N-methyl-3- (1-methyl-4-piperidine)-1,4-indole-5-ethyl thiamine
05/16/2007CN1315810C Piperazine-bridged tacrine binary derivatives and synthesis method thereof
05/16/2007CN1315809C Quinoline derivatives and their use as 5-HT6 ligands
05/16/2007CN1315806C Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors
05/15/2007USRE39634 treatment of neuropathic pain; elevate levels of anandamide or other endogenous cannabinoids to increase the nociceptive threshold
05/15/2007US7217826 Making intermediates to alpha-ethyl-2-oxo-1-pyrrolidine acetamide, also referred to as levetiracetam an antihypoxic agent and antiischemic agent; by reduction via catalytic hydrogenation of an alkenyl intermediate
05/15/2007US7217732 Cannabinoid receptor agonists
05/15/2007US7217729 4,6-Dimethyl-3-{[3'-(N,N-dimethylaminomethyl)-4-hydroxy-4'-(3''-methoxyphenyl)-cyclohexylamino]-methyl}-1H-indole 2-carboxylic acid ethyl ester or other derivatives of substituted indoles; for treatment or prevention of neurodegenerative diseases, psychological disorders, AIDS, inflammation or allergies
05/15/2007US7217728 For therapy of reperfusion injury
05/15/2007US7217724 2-[(2-hydroxy-2-pyridinylethyl)amino]ethyl-substituted indoles, e.g., N,N-Diethyl-2-{3-[(2R)-2-((2R)-2-hydroxy-2-pyridin-3-ylethylamino)-propyl]-1H-indol-7-yloxy}acetamide; beta 3-adrenoceptor stimulants, used for treating obesity, hyperglycemia, frequent urination, and urinary incontinence
05/15/2007US7217722 Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same
05/15/2007US7217720 Benzimidazolyl- or N-hetero analog derivatives of 4-aza-5 alpha -androstan-3-ones, e.g., beta -(1H-imidazo[4,5-c]pyridin-2-yl)-4-methyl-4-aza-5 alpha -androst-1-en-3-one; treatment of conditions caused by androgen deficiency
05/15/2007US7217716 Such as 4-((methyl-pyrimidin-2-ylamino)-methyl)-piperidine-1-carboxylic acid benzyl ester; useful for pain relief; treating migraine, depression, anxiety, schizophrenia, Parkinson's disease, and stroke; N-methyl-D-aspartate NR2B antagonists
05/15/2007US7217714 1-(3-carboxamido-3-phenylpropyl)piperidin-4-yl -triazole or oxazole derivatives, for treatment and prevention of infection by HIV-1 and genetically related retroviruses
05/15/2007US7217713 N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase
05/15/2007US7217712 4-Substituted-5-cyano-1H-pyrimidin-6-(thi)ones as GSK-3 inhibitors
05/15/2007US7217707 Amide of R-2-(aminoaryl)-propionic acid for use in the prevention of leucocyte activation
05/15/2007US7217706 Benzocycloheptenylamino derivatives; treatment of pollakiuria or urinary incontinence
05/15/2007CA2392973C Benzoimidazole derivatives useful as antiproliferative agents
05/15/2007CA2374767C Optically active quinoline carboxylic acid derivatives having 7-pyrrolidine substitutes causing optical activity and a process for preparing thereof
05/15/2007CA2295087C Gastrokinetic monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
05/15/2007CA2155275C Aminoalkyloximes, a process for their preparation, their use as medicaments and intermediate compounds
05/15/2007CA2148612C 2-fluoroalkyl-substituted benzimidazoles, their preparation and their use as pesticides
05/15/2007CA2116167C One-component coating compositions containing oxime- or lactam-blocked polyisocyanates which have improved resistance to yellowing
05/10/2007WO2007053819A2 Pyrrolidinyl beta-amino amide-based inhibitors of dipeptidyl peptidase iv and methods
05/10/2007WO2007053765A2 Substituted cycloalkylpyrrolones as allosteric modulators of glucokinase
05/10/2007WO2007053662A1 Dihydroisoindolones as allosteric modulators of glucokinase
05/10/2007WO2007053657A1 Substituted pyrrolones as allosteric modulators of glucokinase
05/10/2007WO2007053503A1 Substituted dihydroisoindolones as allosteric modulators of glucokinase